drugset / Trial / NCT00259311
Efficacy Study of LY2422347 to Treat Insomnia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether a compound known as LY2422347 is effective in treating people diagnosed with primary insomnia (difficulty sleeping with no other significant contributing factor, such as depression).
Timeline
- Start
- 2005-11
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRUVANSERIN | Small molecule | 5 mg | — |
| Subject | PRUVANSERIN | Small molecule | 15 mg | — |